Quantum Healthcare Limited (SGX:V8Y)
Singapore
· Delayed Price · Currency is SGD 0.0010
0.00 (0.00%)
At close: Apr 28, 2026
Quantum Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 13.06 | 12.69 | 13.08 | 9.37 | - | Upgrade
|
| Revenue Growth (YoY) | 2.99% | -3.03% | 39.63% | - | - | Upgrade
|
| Cost of Revenue | 7.13 | 7.03 | 7.32 | 5.02 | - | Upgrade
|
| Gross Profit | 5.93 | 5.66 | 5.76 | 4.35 | - | Upgrade
|
| Selling, General & Admin | 6.46 | 6.89 | 8.73 | 6.61 | 3.26 | Upgrade
|
| Research & Development | - | - | - | 0.74 | - | Upgrade
|
| Other Operating Expenses | -0.21 | -0.16 | -0.18 | -0.09 | 0 | Upgrade
|
| Operating Expenses | 6.24 | 6.73 | 8.55 | 7.27 | 3.26 | Upgrade
|
| Operating Income | -0.31 | -1.08 | -2.79 | -2.92 | -3.26 | Upgrade
|
| Interest Expense | -0.35 | -0.46 | -0.49 | -0.45 | -0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0 | -0.04 | Upgrade
|
| EBT Excluding Unusual Items | -0.66 | -1.54 | -3.28 | -3.37 | -3.34 | Upgrade
|
| Impairment of Goodwill | -2.19 | -1.01 | - | -4.63 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0.02 | - | -0.79 | 0.14 | Upgrade
|
| Asset Writedown | - | - | - | - | -2.11 | Upgrade
|
| Other Unusual Items | 0 | - | - | - | - | Upgrade
|
| Pretax Income | -2.85 | -2.52 | -3.28 | -8.78 | -5.31 | Upgrade
|
| Income Tax Expense | 0.07 | 0.04 | 0.1 | 0.12 | - | Upgrade
|
| Earnings From Continuing Operations | -2.91 | -2.56 | -3.38 | -8.9 | -5.31 | Upgrade
|
| Minority Interest in Earnings | 0.17 | 0.33 | -0.24 | -0.17 | 0.03 | Upgrade
|
| Net Income | -2.74 | -2.23 | -3.62 | -9.07 | -5.28 | Upgrade
|
| Net Income to Common | -2.74 | -2.23 | -3.62 | -9.07 | -5.28 | Upgrade
|
| Shares Outstanding (Basic) | 8,289 | 7,947 | 7,327 | 6,751 | 2,260 | Upgrade
|
| Shares Outstanding (Diluted) | 8,289 | 7,947 | 7,327 | 6,751 | 2,260 | Upgrade
|
| Shares Change (YoY) | 4.30% | 8.46% | 8.53% | 198.73% | 4.08% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Free Cash Flow | 1.89 | 1.1 | -0.93 | -2.23 | -1.3 | Upgrade
|
| Free Cash Flow Per Share | - | - | - | - | -0.00 | Upgrade
|
| Gross Margin | 45.41% | 44.60% | 44.03% | 46.42% | - | Upgrade
|
| Operating Margin | -2.39% | -8.48% | -21.34% | -31.14% | - | Upgrade
|
| Profit Margin | -21.00% | -17.61% | -27.68% | -96.78% | - | Upgrade
|
| Free Cash Flow Margin | 14.47% | 8.63% | -7.08% | -23.76% | - | Upgrade
|
| EBITDA | 0.24 | -0.56 | -2.31 | -2.59 | -3.17 | Upgrade
|
| EBITDA Margin | 1.80% | -4.38% | -17.68% | -27.62% | - | Upgrade
|
| D&A For EBITDA | 0.55 | 0.52 | 0.48 | 0.33 | 0.09 | Upgrade
|
| EBIT | -0.31 | -1.08 | -2.79 | -2.92 | -3.26 | Upgrade
|
| EBIT Margin | -2.39% | -8.48% | -21.34% | -31.14% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.